相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Perturbation of the gut microbiome by Prevotella spp. enhances host susceptibility to mucosal inflammation
Aida Iljazovic et al.
MUCOSAL IMMUNOLOGY (2021)
FXR in the dorsal vagal complex is sufficient and necessary for upper small intestinal microbiome-mediated changes of TCDCA to alter insulin action in
Song-Yang Zhang et al.
GUT (2021)
MUC2 and related bacterial factors: Therapeutic targets for ulcerative colitis
Dianbo Yao et al.
EBIOMEDICINE (2021)
Bile Acid-Gut Microbiota Axis in Inflammatory Bowel Disease: From Bench to Bedside
Min Yang et al.
NUTRIENTS (2021)
Gut microbiota-derived metabolites as key actors in inflammatory bowel disease
Aonghus Lavelle et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Sudabeh Alatab et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Modulation of gut mucosal microbiota as a mechanism of probiotics-based adjunctive therapy for ulcerative colitis
Ping Chen et al.
MICROBIAL BIOTECHNOLOGY (2020)
Bile Acids and GPBAR-1: Dynamic Interaction Involving Genes, Environment and Gut Microbiome
Piero Portincasa et al.
NUTRIENTS (2020)
Taurocholic acid lowers the inflammatory response of gingival fibroblasts, epithelial cells, and macrophages
Reza Talebian et al.
JOURNAL OF ORAL SCIENCE (2020)
IL-10 produced by macrophages regulates epithelial integrity in the small intestine
Tina L. Morhardt et al.
SCIENTIFIC REPORTS (2019)
Intestinal Bacteria Interplay With Bile and Cholesterol Metabolism: Implications on Host Physiology
Natalia Molinero et al.
FRONTIERS IN PHYSIOLOGY (2019)
Emerging roles of bile acids in mucosal immunity and inflammation
Mei Lan Chen et al.
MUCOSAL IMMUNOLOGY (2019)
Inflammation-induced Occludin Downregulation Limits Epithelial Apoptosis by Suppressing Caspase-3 Expression
Wei-Ting Kuo et al.
GASTROENTEROLOGY (2019)
Keep calm: the intestinal barrier at the interface of peace and war
Lester Thoo et al.
CELL DEATH & DISEASE (2019)
The gut microbiome: Relationships with disease and opportunities for therapy
Juliana Durack et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
Taurochenodeoxycholic Acid Inhibited AP-1 Activation via Stimulating Glucocorticoid Receptor
Lei Li et al.
MOLECULES (2019)
Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
Wei Jia et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Inflammatory bowel disease and immunonutrition: novel therapeutic approaches through modulation of diet and the gut microbiome
Larissa S. Celiberto et al.
IMMUNOLOGY (2018)
Determinants of IBD Heritability: Genes, Bugs, and More
Williams Turpin et al.
INFLAMMATORY BOWEL DISEASES (2018)
Bile Acids Activated Receptors Regulate innate immunity
Stefano Fiorucci et al.
FRONTIERS IN IMMUNOLOGY (2018)
Review article: the gut microbiome in inflammatory bowel diseaseavenues for microbial management
J. McIlroy et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Mechanisms regulating intestinal barrier integrity and its pathological implications
Chaithanya Chelakkot et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
Daily intake of fermented milk with Lactobacillus casei strain Shirota reduces the incidence and duration of upper respiratory tract infections in healthy middle-aged office workers
Kan Shida et al.
EUROPEAN JOURNAL OF NUTRITION (2017)
Probiotics in Inflammatory Bowel Disease
Bincy P. Abraham et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2017)
TUDCA: An Agonist of the Bile Acid Receptor GPBAR1/TGR5 With Anti-Inflammatory Effects in Microglial Cells
Natalia Yanguas-Casas et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2017)
Gynostemma pentaphyllum saponins attenuate inflammation in vitro and in vivo by inhibition of NF-κB and STAT3 signaling
Wing-Yan Wong et al.
ONCOTARGET (2017)
Mend Your Fences The Epithelial Barrier and its Relationship With Mucosal Immunity in Inflammatory Bowel Disease
Eva Martini et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2017)
Ursodeoxycholic Acid and Its Taurine- or Glycine-Conjugated Species Reduce Colitogenic Dysbiosis and Equally Suppress Experimental Colitis in Mice
Lien Van den Bossche et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2017)
The Effectiveness of Lactobacillus Beverages in Controlling Infections among the Residents of an Aged Care Facility: A Randomized Placebo-Controlled Double-Blind Trial
Satoru Nagata et al.
ANNALS OF NUTRITION AND METABOLISM (2016)
Mechanistic study of the anti-cancer effect of Gynostemma pentaphyllum saponins in the ApcMin/+ mouse model
William Chi-Shing Tai et al.
PROTEOMICS (2016)
Proteomic profiling of dextran sulfate sodium induced acute ulcerative colitis mice serum exosomes and their immunomodulatory impact on macrophages
Wing-Yan Wong et al.
PROTEOMICS (2016)
Probiotics in the Management of Ulcerative Colitis
Richa Chibbar et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2015)
The global burden of IBD: from 2015 to 2025
Gilaad G. Kaplan
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2015)
Muricholic bile acids are potent regulators of bile acid synthesis via a positive feedback mechanism
X. Hu et al.
JOURNAL OF INTERNAL MEDICINE (2014)
Tauroursodeoxycholic acid inhibits experimental colitis by preventing early intestinal epithelial cell death
Debby Laukens et al.
LABORATORY INVESTIGATION (2014)
IL-10 modulates DSS-induced colitis through a macrophage-ROS-NO axis
B. Li et al.
MUCOSAL IMMUNOLOGY (2014)
Spontaneous Colitis in Muc2-Deficient Mice Reflects Clinical and Cellular Features of Active Ulcerative Colitis
Ulf A. Wenzel et al.
PLOS ONE (2014)
Quantification of multiple bile acids in uninephrectomized rats using ultra-performance liquid chromatography-tandem mass spectrometry
Carlos A. Penno et al.
ANALYTICAL METHODS (2013)
The Unfolded Protein Response and Chemical Chaperones Reduce Protein Misfolding and Colitis in Mice
Stewart Siyan Cao et al.
GASTROENTEROLOGY (2013)
Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases
Henri Duboc et al.
GUT (2013)
Mucosal Barrier in Ulcerative Colitis and Crohn's Disease
A. E. Dorofeyev et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2013)
Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity
Fei Li et al.
NATURE COMMUNICATIONS (2013)
Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease
Raffaella M. Gadaleta et al.
GUT (2011)
Expression and function of the bile acid receptor GpBAR1 (TGR5) in the murine enteric nervous system
D. P. Poole et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2010)
Ubiquitination and Degradation of the Inhibitors of NF-κB
Naama Kanarek et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
The regulation of IL-10 production by immune cells
Margarida Saraiva et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Inflammatory Bowel Disease and Mutations Affecting the Interleukin-10 Receptor
Erik-Oliver Glocker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Mechanisms of proteasome inhibitor action and resistance in cancer
David J. McConkey et al.
DRUG RESISTANCE UPDATES (2008)
Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility
Andre Franke et al.
NATURE GENETICS (2008)
Unravelling the pathogenesis of inflammatory bowel disease
R. J. Xavier et al.
NATURE (2007)
Interleukin-10 in the pathophysiology of inflammatory bowel disease: Increased serum concentrations during the recovery phase
Keiichi Mitsuyama et al.
MEDIATORS OF INFLAMMATION (2006)
Occludin: Structure, function and regulation
GJ Feldman et al.
ADVANCED DRUG DELIVERY REVIEWS (2005)
Effects. of a fennented milk drink containing Lactobacillus casei strain Shirota on the immune system in healthy human subjects
F Nagao et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2000)